Naturalendo Tech Co., Ltd. (KOSDAQ:168330)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,675.00
-95.00 (-2.52%)
At close: Jul 18, 2025, 3:30 PM KST
72.94%
Market Cap116.03B
Revenue (ttm)23.27B
Net Income (ttm)-3.54B
Shares Out31.57M
EPS (ttm)-111.77
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume310,288
Average Volume297,467
Open3,730.00
Previous Close3,770.00
Day's Range3,560.00 - 3,795.00
52-Week Range1,262.00 - 6,300.00
Beta0.10
RSI55.26
Earnings DateSep 12, 2025

About Naturalendo Tech

Naturalendo Tech Co., Ltd. engages in the research, development, manufacturing, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; Seoul National University wonder, a diet ingredient; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a m... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Employees 74
Stock Exchange KOSDAQ
Ticker Symbol 168330
Full Company Profile

Financial Performance

In 2024, Naturalendo Tech's revenue was 22.26 billion, an increase of 18.48% compared to the previous year's 18.79 billion. Losses were -3.89 billion, -11.04% less than in 2023.

Financial Statements

News

There is no news available yet.